Sign in
4

Changes in Ownership

KALA BIO, Inc. Filed Acc 0001179110-17-012839

Options or other derivatives

  • Director acquired 25,920 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

KOVEN ANDREW I · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2017-09-28 Grant or award : show line 1 in the form Stock Option (right to buy) +25,920 $23.08 2027-09-28 25,920 25,920 D
Loading xslF345X03/edgar.xml…